With FDA Alignment and a positive Phase 2 clinical trial for its Next Generation TKI, Ashvattha Therapeutics prepares for a Phase 2b/3 trial Montgomery brings decades of experience in Life Sciences ...
Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results